Tiotropium plus formoterol versus tiotropium alone for stable moderate-to-severe chronic obstructive pulmonary disease: A meta-analysis

Author:

Zou Yong1,Xiao Jian1,Lu Xiao Xiao1,Xia Zi An2,Xie Bin1,Li Jun3,Chen Qiong1

Affiliation:

1. Department of Gerontology and Respiratory Diseases; Xiangya Hospital, Central South University, 136 Xiangya Road; Changsha Hunan 410008 People's Republic of China

2. Institute of Integrated Traditional Chinese and Western Medicine, Xiangya Hospital, Central South University; Changsha Hunan 410008 People's Republic of China

3. Thyroid Tumour Internal Medicine Department; Cancer Hospital affiliated to Xiangya School of Medicine, Central South University; Changsha Hunan 410013 People's Republic of China

Publisher

Wiley

Subject

Genetics(clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Reference28 articles.

1. GOLD http://www.goldcopd.org/uploads/users/files/GOLD_Report2014_Feb07.pdf 2014

2. Chronic obstructive pulmonary disease global strategy for the diagnosis, management, and prevention of;Rabe;Am J Respir Crit Care Med.,2007

3. WHO http://www.who.int/respiratory/copd/WorldHealthStatistics˙2008/en/index.html# 2012

4. Global burden of COPD: risk factors, prevalence, and future trends;Mannino;Lancet.,2007

5. Beta2-agonist and anticholinergic drugs in the treatment of lung disease;Proskocil;Proc Am Thorac Soc.,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3